<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Encounter Summary</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body>
<h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Encounter Details</a></li><li><a href="#id2">Social History</a></li><li><a href="#id3">Last Filed Vital Signs</a></li><li><a href="#id4">Functional Status</a></li><li><a href="#id5">Patient Instructions</a></li><li><a href="#id6">Progress Notes</a></li><li><a href="#id7">Plan of Treatment</a></li><li><a href="#id8">Goals</a></li><li><a href="#id9">Procedures</a></li><li><a href="#id10">Results</a></li><li><a href="#id11">Visit Diagnoses</a></li><li><a href="#id12">Administered Medications</a></li><li><a href="#id13">Additional Health Concerns</a></li><li><a href="#id14">Care Teams</a></li><li><a href="#id15">Additional Source Comments</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Encounter Details</a></h3><div><table><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter1" class="xRowNormal"><td>[REDACTED] 10:00 AM EST</td><td ID="encounter1type">Office Visit</td><td><p>Lank Center for Genitourinary Oncology, [REDACTED] Cancer Institute</p><p>[REDACTED]</p><p>Yawkey Ctr, Fl 11</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td><span class="content_span">Prostate cancer metastatic to bone (Primary Dx)</span></td></tr></tbody></table></div><h3><a name="id2" href="#toc">Social History</a></h3><div><table ID="sochist6"><colgroup><col width="25%" span="2"/><col width="13%"/><col width="12%"/><col width="25%"/></colgroup><thead><tr><th>Tobacco Use</th><th>Types</th><th>Packs/Day</th><th>Years Used</th><th>Date</th></tr></thead><tbody><tr><td>Smoking Tobacco: Former</td><td>Cigarettes</td><td ID="sochist6packsperday">1</td><td>19</td><td>[REDACTED] - [REDACTED]</td></tr><tr ID="sochist6smokeless" class="xRowAlt"><td>Smokeless Tobacco: Never</td><td/><td/><td/><td/></tr></tbody></table><table><colgroup><col width="25%" span="2"/><col width="50%"/></colgroup><thead><tr><th>Alcohol Use</th><th>Standard Drinks/Week</th><th>Comments</th></tr></thead><tbody><tr><td ID="alcoholStatus">Not Currently</td><td>0 (1 standard drink = 0.6 oz pure alcohol)</td><td/></tr></tbody></table><table><colgroup><col width="50%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Sex and Gender Information</th><th>Value</th><th>Date Recorded</th></tr></thead><tbody><tr ID="BirthSex9"><td>Sex Assigned at Birth</td><td ID="BirthSex9Value">Male</td><td>[REDACTED]  6:23 PM EDT</td></tr><tr ID="GenderIdentity7"><td>Gender Identity</td><td ID="GenderIdentity7Value">Male</td><td>[REDACTED]  6:23 PM EDT</td></tr><tr ID="SexualOrientation8"><td>Sexual Orientation</td><td ID="SexualOrientation8Value">Straight</td><td>[REDACTED]  6:23 PM EDT</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id3" href="#toc">Last Filed Vital Signs</a></h3><div><table><colgroup><col width="25%" span="4"/></colgroup><thead><tr><th>Vital Sign</th><th>Reading</th><th>Time Taken</th><th>Comments</th></tr></thead><tbody><tr class="xRowNormal"><td class="xcellHeader">Blood Pressure</td><td><span class="content_span">174</span>/<span class="content_span">90</span></td><td>[REDACTED] 10:17 AM EST</td><td/></tr><tr ID="pulse_5749024620" class="xRowAlt"><td class="xcellHeader">Pulse</td><td>69</td><td>[REDACTED] 10:17 AM EST</td><td/></tr><tr ID="temp_5749024320" class="xRowNormal"><td class="xcellHeader">Temperature</td><td>36.1 °C (97 °F)</td><td>[REDACTED] 10:12 AM EST</td><td/></tr><tr ID="resp_5749024320" class="xRowAlt"><td class="xcellHeader">Respiratory Rate</td><td>20</td><td>[REDACTED] 10:12 AM EST</td><td/></tr><tr ID="SpO2_5749024510" class="xRowNormal"><td class="xcellHeader">Oxygen Saturation</td><td>99%</td><td>[REDACTED] 10:15 AM EST</td><td/></tr><tr ID="inhaled_" class="xRowAlt"><td class="xcellHeader">Inhaled Oxygen Concentration</td><td>-</td><td>-</td><td/></tr><tr ID="weight_5749024320" class="xRowNormal"><td class="xcellHeader">Weight</td><td>106.6 kg (235 lb 0.2 oz)</td><td>[REDACTED] 10:12 AM EST</td><td/></tr><tr ID="height_" class="xRowAlt"><td class="xcellHeader">Height</td><td>-</td><td>-</td><td/></tr><tr ID="bmi_5749024320" class="xRowNormal"><td class="xcellHeader">Body Mass Index</td><td>36.81</td><td>[REDACTED]  9:43 AM EST</td><td/></tr></tbody></table>documented in this encounter</div><h3><a name="id4" href="#toc">Functional Status</a></h3><div><span class="content_span">Not on file</span>documented as of this encounter</div><h3><a name="id5" href="#toc">Patient Instructions</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id6" href="#toc">Progress Notes</a></h3><div><ul><li>[REDACTED], MD - [REDACTED] 10:00 AM EST: <content><content><span class="xLabel">Formatting of this note is different from the original.</span><br/>[REDACTED] Cancer Institute<br/>Genitourinary Medical Oncology<br/>Follow-up Visit<br/><br/>[REDACTED] Date: [REDACTED] <br/><br/>Patient ID/CC: [REDACTED] is a [REDACTED]. male with HTN, T2DM, HLD, heart failure (grade 3 DD on TTE in 04/20, EF 36% on nuclear stress in 01/21), OSA, gout, hyperparathyroidism, retained bullet near his spine, and localized prostate cancer s/p RT plus ADT in [REDACTED], now with mCRPC previously treated with abiraterone, olaparib, radium-223, and enzalutamide, currently on cabazitaxel.<br/><br/>Chief Complaint: [REDACTED] is here [REDACTED] ([REDACTED]) for follow-up of his prostate cancer, for monitoring on ADT and cabazitaxel, and to review recent labs.<br/><br/>Interval History:<br/>[REDACTED] presents [REDACTED] accompanied by his supportive partner.<br/>He reports feeling at baseline [REDACTED] from a cardiopulmonary standpoint. SOB is at baseline. He took torsemide 30 mg this morning.<br/>He has otherwise felt well since his last visit with no other new or bothersome symptoms or changes to his health.<br/>We reviewed potential symptoms pertaining to his general health, skin, ENT, cardiovascular, respiratory, GI, GU, MSK, and neurologic systems, all of which were otherwise negative.<br/><br/>Oncology History Overview Note <br/>2009: Prostate biopsy showed prostate cancer in 13/13 cores including [REDACTED] 4+3 in 2 cores (up to 80%) and [REDACTED] 3+4 in 11 cores. Treated with EBRT plus 6 months of [REDACTED]. PSA nadir 0.2.<br/>2011: PSA 5.6. Started on lupron.<br/>2012: PSA nadir 0.1.<br/>2014: PSA 0.5 consistent with CRPC. Started on bicalutamide. Questionable osseous mets on bone scan.<br/>2015: PSA 1.4. Switched from [REDACTED] to nilutamide. Bone scan shows progression consistent with osseous metastases consistent with mCRPC.<br/>2016: PSA 1.7. Received palliative RT to T10-L3. Stopped Nilutamide and started flutamide.<br/>2017: PSA nadir at 0.9, but increased to 1.3 with radiographic progression and started on abiraterone in [REDACTED].<br/>07/2018: Received palliative RT to T4 spine and L humerus.<br/>09/2019: PSA nadir at 0.8 on Abiraterone.<br/>08/2020: Lung biopsy showed ATM E2304Ffs*69. Germline analysis with no pathogenic alterations.<br/>[REDACTED]: Stopped Abiraterone due to progression. Started olaparib 300 mg BID.<br/>[REDACTED]: Olaparib decreased to 150 mg BID due to concern for gout flare.<br/>[REDACTED]: Olaparib increased back to 300 mg BID.<br/>[REDACTED]: Bone scan and CT showed stable active bone metastasis in the in the T4, T11, and L2 vertebral bodies and in the distal right humerus. Interval increase in size of mediastinal and hilar lymphadenopathy up to 3 cm. Subcutaneous 1.0 cm soft tissue nodule in right medial thigh, increased in size from 0.6 cm.<br/>[REDACTED]: Olaparib stopped by patient due to bone pain.<br/>[REDACTED]: Lupron 22.5 mg given.<br/>[REDACTED]: Initial DFCI consult. PSA 2.97, testosterone &lt; 7.<br/>[REDACTED]: CT C/A/P showed mild increase in mediastinal LAD (largest is a 2.5 cm subcarinal LN conglomerate). Bone scan overall similar.<br/>[REDACTED]: PSA 3.58. Plan to start docetaxel, but he had severe hyperglycemia with the dexamethasone pre-medication.<br/>[REDACTED]: Start enzalutamide.<br/>[REDACTED]: PSA 3.20.<br/>[REDACTED]: PSA 3.65.<br/>[REDACTED]: PSA 4.36.<br/>[REDACTED]: CT C/A/P and bone scan showed overall stable disease.<br/>[REDACTED]: PSA 6.07<br/>[REDACTED]: Enza reduced from 160 mg to 120 mg due to fatigue and weakness.<br/>[REDACTED]: PSA 5.17, started Xgeva q 4-6 weeks. <br/>[REDACTED]: PSA 6.50. Patient reduced Enza to 80 mg for previous few weeks. Trial increasing to 120 mg daily.<br/>[REDACTED]: CT and bone scan showed new focal radiotracer uptake in the posterior left intertrochanteric region consistent with oligo-progressive disease.<br/>[REDACTED]: Xofigo #1. <br/>[REDACTED]: Xofigo #2. <br/>[REDACTED]: Xofigo #3.<br/>[REDACTED]: Xofigo #4. <br/>[REDACTED]: Xofigo #5. <br/>[REDACTED]: Underwent a CABG at BMC. Stopped enzalutamide.<br/>[REDACTED]: CT and bone scan showed progression in osseous lesions in T9, left femur, mediastinal lymph nodes, and new lesions in left lateral sixth rib.<br/>[REDACTED]: CT CAP showed slight increase in subcarinal LN mass (6.5 x 3.0 cm) with invasion into the airway and newly enlarged bilateral supraclavicular LNs (up to 1 cm), slight increase in size of RP LNs (up to 1.2 cm); bone scan showed similar osseous metastatic disease burden on the bone scan involving the T9 and left proximal femur.<br/>[REDACTED]: Underwent EBUS which showed extensive airway disease in the lower tracheal around the main carina all the way down to the distal left mainstem bronchus, characterized by a combination of infiltrative and exophytic disease and to a lesser extent extrinsic compression. Biopsy of the subcarinal mass showed metastatic prostate adenocarcinoma. Oncopanel showed bi-allelic ATM loss (frameshift/1DEL); no other targetable alterations.<br/>[REDACTED]: C1 cabazitaxel chemotherapy. <br/> <br/>Malignant neoplasm of prostate <br/>[REDACTED] Initial Diagnosis <br/> Prostate cancer<br/> <br/>[REDACTED] - [REDACTED] Systemic Therapy <br/> Palliative; DOCETAXEL 75 MG/M2 EVERY 3 WEEKS<br/>[REDACTED], MD<br/><br/> <br/>[REDACTED] - [REDACTED] Systemic Therapy <br/> Control; DOCETAXEL 75 MG/M2 EVERY 3 WEEKS<br/>[REDACTED], MD<br/><br/> <br/>[REDACTED] -  Systemic Therapy <br/> Palliative; CABAZITAXEL<br/>[REDACTED], MD<br/><br/> <br/>Bone metastasis <br/>[REDACTED] Initial Diagnosis <br/> Bone metastasis<br/> <br/>Prostate cancer metastatic to bone <br/>[REDACTED] Initial Diagnosis <br/> Prostate cancer metastatic to bone<br/> <br/>[REDACTED] - [REDACTED] Systemic Therapy <br/> Control; DOCETAXEL 75 MG/M2 EVERY 3 WEEKS<br/>[REDACTED], MD<br/><br/> <br/>[REDACTED] -  Systemic Therapy <br/> Palliative; CABAZITAXEL<br/>[REDACTED], MD<br/><br/> <br/>?<br/>Past Medical History: <br/>Diagnosis Date <br/>• Anemia  <br/>• CAD (coronary artery disease)  <br/> s/p CABG [REDACTED] <br/>• CHF (congestive heart failure)  <br/>• Chronic kidney disease (CKD)  <br/>• Diabetes mellitus, type 2  <br/>• Hyperlipidemia  <br/>• Hypertensive disorder  <br/>• NSTEMI (non-ST elevated myocardial infarction) 06/2022 <br/>• OSA (obstructive sleep apnea)  <br/>• Osteoarthritis  <br/>• Prostate cancer  <br/> On lupron/ezalutamide <br/><br/>Past Surgical History: <br/>Procedure Laterality Date <br/>• BRONCHOSCOPY FLEXIBLE N/A [REDACTED] <br/> Procedure: BRONCHOSCOPY FLEXIBLE WITH CRYO;  Surgeon: [REDACTED], MD, MPH;  Location: BWH OR;  Service: Interventional Pulmonology <br/>• BRONCHOSCOPY FLEXIBLE N/A [REDACTED] <br/> Procedure: BRONCHOSCOPY FLEXIBLE WITH CRYO;  Surgeon: [REDACTED], MD, MPH;  Location: BWH OR;  Service: Interventional Pulmonology <br/>• BRONCHOSCOPY FLEXIBLE N/A [REDACTED] <br/> Procedure: BRONCHOSCOPY FLEXIBLE WITH CRYO;  Surgeon: [REDACTED], MD, MPH;  Location: BWH OR;  Service: Interventional Pulmonology <br/>• CORONARY ARTERY BYPASS GRAFT  06/2022 <br/> BMC <br/>• ENDOBRONCHIAL ULTRASOUND N/A [REDACTED] <br/> Procedure: ENDOBRONCHIAL ULTRASOUND;  Surgeon: [REDACTED], MD, MPH;  Location: BWH OR;  Service: Interventional Pulmonology <br/> <br/>No family history on file. <br/><br/>Social History <br/><br/>Socioeconomic History <br/>• Marital status: Life Partner <br/>  Spouse name: Not on file <br/>• Number of children: Not on file <br/>• Years of education: Not on file <br/>• Highest education level: Not on file <br/>Occupational History <br/>• Not on file <br/>Tobacco Use <br/>• Smoking status: Former <br/>  Packs/day: 1.00 <br/>  Years: 19.00 <br/>  Pack years: 19.00 <br/>  Types: Cigarettes <br/>  Quit date: [REDACTED] <br/>  Years since quitting: 34.0 <br/>• Smokeless tobacco: Never <br/>Substance and Sexual Activity <br/>• Alcohol use: Not Currently <br/>• Drug use: Never <br/>• Sexual activity: Not on file <br/>Other Topics Concern <br/>• Not on file <br/>Social History Narrative <br/> Retired taxi driver, lives with longtime girlfriend; has an adult daughter <br/><br/>Social Determinants of Health <br/><br/>Allergies and medications personally reviewed in clinic [REDACTED] ([REDACTED]).<br/>?<br/>Allergies <br/>Allergen Reactions <br/>• Other Angioedema <br/>  Allergy is actually to the pesticide on the skins of fresh fruit, not fruit itself. Pt gets itchy throat, vomiting <br/>?<br/>Current Outpatient Medications Ordered in Epic <br/>Medication Sig <br/>• acetaminophen (TYLENOL) 325 mg tablet Take 325 mg by mouth every 6 (six) hours as needed. <br/>• albuterol 90 mcg/actuation inhaler INHALE TWO (2) PUFFS INTO THE LUNGS EVERY SIX (6) (SIX) HOURS AS NEEDED FOR WHEEZING. <br/>• aspirin 81 MG EC tablet Take 81 mg by mouth daily. <br/>• atorvastatin (LIPITOR) 80 MG tablet Take 1 tablet (80 mg total) by mouth daily. <br/>• benzonatate (TESSALON) 100 MG capsule Take 1 capsule (100 mg total) by mouth 3 (three) times a day as needed for cough. <br/>• budesonide-formoterol (SYMBICORT) 160-4.5 mcg/actuation inhaler Inhale 2 puffs into the lungs 2 (two) times a day. <br/>• calcium carbonate (OS-CAL) 1,250 mg (500 mg elemental) tablet Take 1 tablet (1,250 mg total) by mouth 2 (two) times a day with meals. <br/>• carvedilol (COREG) 25 MG tablet Take 1 tablet (25 mg total) by mouth 2 (two) times a day with meals. <br/>• empagliflozin (JARDIANCE) 10 mg tablet Take 1 tablet (10 mg total) by mouth daily. <br/>• leuprolide, 3 month, (LUPRON DEPOT 3 MONTH) 22.5 mg IM injection syringe Inject 22.5 mg into the muscle every 3 (three) months. <br/>• loperamide (IMODIUM A-D) 2 mg tablet Take 1 tablet (2 mg total) by mouth 4 (four) times a day as needed for diarrhea. <br/>• magnesium oxide (MAG-OX) 400 mg (241.3 mg elemental) tablet TAKE ONE (1) TABLET (400 MG TOTAL) BY MOUTH DAILY. <br/>• melatonin 3 mg Tab Take 1-2 tablets (3-6 mg total) by mouth nightly at bedtime as needed. <br/>• metFORMIN (GLUCOPHAGE-XR) 500 MG 24 hr tablet Take 1 tablet (500 mg total) by mouth daily with breakfast. <br/>• omeprazole (PRILOSEC) 20 MG capsule TAKE 1 CAPSULE(20 MG) BY MOUTH EVERY MORNING BEFORE BREAKFAST <br/>• sacubitriL-valsartan (ENTRESTO) 24-26 mg per tablet Take 1 tablet by mouth 2 (two) times a day. <br/>• torsemide (DEMADEX) 10 MG tablet Take 2 tablets (20 mg total) by mouth daily. <br/><br/>Physical Exam:<br/>Vitals: <br/> [REDACTED] 1017 <br/>BP: (!) 174/90 <br/>Pulse: 69 <br/>Resp:  <br/>Temp:  <br/>SpO2:  <br/> <br/>General: Well-appearing patient in no acute distress.<br/>?HEENT: Sclerae are anicteric. EOMI.<br/>Neck: Supple.<br/>Heart: Normal heart rate.<br/>Lungs: Breathing is non-labored. Speaking in full sentences.<br/>Abdomen: Non-distended.<br/>Extremities: No lower extremity edema.<br/>Neurologic: Alert and oriented to time, place and self. Distal sensory and motor function is grossly preserved. Normal gait.<br/>Psychiatric: Appropriate mood and affect. <br/>Skin: No visible rashes.<br/><br/>Data:<br/>Results for orders placed or performed in visit on [REDACTED] <br/>CBC and differential <br/> Collection Time: [REDACTED] 10:06 AM <br/> Specimen: Blood <br/>Result Value Ref Range <br/> WBC 3.24 (L) 3.81 - 8.94 K/uL <br/> RBC 3.94 (L) 4.35 - 5.61 M/uL <br/> HGB 9.8 (L) 12.5 - 16.3 g/dL <br/> HCT 30.9 (L) 37.1 - 49.5 % <br/> PLT 134 (L) 152 - 440 K/uL <br/> MCV 78.4 (L) 79.0 - 97.0 fL <br/> MCH 24.8 (L) 26.2 - 32.0 pg <br/> MCHC 31.6 (L) 33.3 - 35.7 g/dL <br/> RDW 16.6 (H) 12.1 - 16.0 % <br/> MPV 10.8 7.0 - 10.8 fl <br/> NRBC 0.00 0 /100 WBCs <br/> ABSOLUTE NRBC Not Reported K/uL <br/> NEUTS 63.2 46.5 - 82.4 % <br/> LYMPHS 21.7 8.5 - 32.7 % <br/> MONOS 10.6 5.4 - 14.2 % <br/> EOS 3.3 0.1 - 6.0 % <br/> BASOS 1.2 (H) 0.1 - 1.1 % <br/> ABSOLUTE NEUTS 2.05 (L) 2.23 - 6.11 K/uL <br/> ABSOLUTE LYMPHS 0.70 0.21 - 2.74 K/uL <br/> ABSOLUTE MONOS 0.35 0.20 - 0.87 K/uL <br/> ABSOLUTE EOS 0.11 0.00 - 0.52 K/uL <br/> ABSOLUTE BASOS 0.04 0.00 - 0.11 K/uL <br/>Urinalysis <br/> Collection Time: [REDACTED] 10:06 AM <br/> Specimen: Urine <br/>Result Value Ref Range <br/> COLOR Colorless (*) Yellow <br/> CLARITY Clear Clear <br/> GLUCOSE 4+ (*) NORMAL <br/> BILI Negative Negative <br/> KETONES Negative Negative <br/> SPECIFIC GRAVITY 1.009 1.003 - 1.035 <br/> BLOOD Negative Negative <br/> PH 6.5 4.6 - 8.0 <br/> Protein-UA Negative Negative <br/> UROBILINOGEN NORMAL NORMAL <br/> NITRITE Negative Negative <br/> Leukocyte esterase, ur Negative Negative <br/> WBC &lt;1 0 - 9 /hpf <br/> RBC None 0 - 2 /hpf <br/> BACTERIA None None /hpf <br/><br/>Assessment and Plan: <br/>[REDACTED] is a [REDACTED]. male with HTN, T2DM, HLD, heart failure (grade 3 DD on TTE in 04/20, EF 36% on nuclear stress in 01/21), OSA, gout, hyperparathyroidism, retained bullet near his spine, and localized prostate cancer s/p RT plus ADT in [REDACTED], now with mCRPC previously treated with abiraterone, olaparib, radium-223, and enzalutamide, currently on cabazitaxel without prednisone.<br/>· PSA [REDACTED] is 27 from 25 at last visit.<br/>· Proceed with cycle 2 cabaziataxel.<br/>· Cabazitaxel chosen over docetaxel given limited steroid exposure with cabazitaxel. He will receive dex x 1 as a pre-med. He will not receive daily prednisone. <br/>· Lupron 22.5 mg IM depot given [REDACTED]; next due on/after [REDACTED]. <br/>· Xgeva given [REDACTED]; continue every 4-6 weeks for mCRPC.<br/>· Biopsy on [REDACTED] confirmed that subcarinal disease is metastatic prostate cancer. Oncopanel showed bi-allelic ATM loss (frameshift/1DEL); no other targetable alterations. Previously trialed PARP inhibitor - stopped due to tolerance, did not progress, could retry.<br/>· SOC treatment options include docetaxel, Lutetium-PSMA, olaparib. Lutetium availability is up in the air due to supply chain. Could try docetaxel again, but previously complicated by severe hyperglycemia with dexamethasone pre-medication.<br/>· He has multiple comobidities that will need to be followed closely on chemotherapy, see below.<br/><br/>Other medical issues:<br/>· Acute on CKD: Baseline Cr 1.7-1.8. Cr [REDACTED] is 1.7.<br/>· CAD s/p CABG / HFpEF / HTN: CABG on [REDACTED] at BMC. He is followed by [REDACTED] at BWH. Dry weight is ~236 lbs. Weight [REDACTED] is 235 lbs.<br/>· Type 2 diabetes: Followed by BWH endocrinology.<br/><br/>DISPO: RTC [REDACTED] for consideration of C3 cabazitaxel chemotherapy. <br/><br/>[REDACTED] verbalized understanding and agreement with the above plan and all of his questions were answered to the best of my ability.<br/><br/>I reviewed and/or updated the assessment and plan [REDACTED] ([REDACTED]) and there are no changes except as documented.<br/><br/>Total time spent [REDACTED] ([REDACTED]) for this visit in face-to-face and non face-to-face time reviewing, obtaining, and documenting clinical information, coordinating with the care team and other specialists, and counseling the patient was 45 minutes.<br/><br/>[REDACTED], MD<br/>Genitourinary Medical Oncologist, [REDACTED] Cancer Institute<br/>Instructor of Medicine, [REDACTED]<br/>[REDACTED]<br/>Pager: 40527<br/>Office: [REDACTED]<br/>Fax: [REDACTED]</content><br/><span class="xLabel">Electronically signed by [REDACTED], MD at [REDACTED] 12:55 PM EST</span><br/></content></li></ul>documented in this encounter</div><h3><a name="id7" href="#toc">Plan of Treatment</a></h3><div><table><span style="font-weight:bold; ">Upcoming Encounters</span><colgroup><col width="10%"/><col width="15%"/><col width="25%" span="3"/></colgroup><thead><tr><th>Date</th><th>Type</th><th>Department</th><th>Care Team (Latest Contact Info)</th><th>Description</th></tr></thead><tbody><tr ID="encounter44" class="xRowNormal"><td>[REDACTED]</td><td ID="encounter44type">Procedure Pass</td><td><p>[REDACTED] Imaging Department, [REDACTED] Cancer Institute, [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td/><td/></tr><tr ID="encounter43" class="xRowAlt"><td>[REDACTED]</td><td ID="encounter43type">Procedure Pass</td><td><p>[REDACTED] Imaging Department, [REDACTED] Cancer Institute, [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] Bldg, Fl L1</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td/><td/></tr><tr ID="encounter49" class="xRowNormal"><td>[REDACTED]  2:30 PM EDT</td><td ID="encounter49type">Appointment</td><td><p>BWH Oral Medicine and Dentistry Practice</p><p>[REDACTED][REDACTED]</p><p>ASB2-1</p><p>[REDACTED], MA 02115</p><p>[REDACTED]</p></td><td><p>[REDACTED], [REDACTED], DMD</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter48" class="xRowAlt"><td>[REDACTED] 12:30 PM EDT</td><td ID="encounter48type">Blood Draw</td><td><p>Laboratory Services, [REDACTED] Cancer Institute</p><p>[REDACTED]</p><p>Yawkey Ctr Fl 2</p><p>[REDACTED], MA 02215</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter47" class="xRowNormal"><td>[REDACTED]  1:30 PM EDT</td><td ID="encounter47type">Office Visit</td><td><p>Lank Center for Genitourinary Oncology, [REDACTED] Cancer Institute</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], NP</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter46" class="xRowAlt"><td>[REDACTED]  1:50 PM EDT</td><td ID="encounter46type">Office Visit</td><td><p>MEE Retina Main Campus</p><p>[REDACTED][REDACTED]</p><p>12th Fl</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD, PhD</p><p>[REDACTED][REDACTED]</p><p>[REDACTED], MA 02114</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter45" class="xRowNormal"><td>[REDACTED]  9:30 AM EDT</td><td ID="encounter45type">Blood Draw</td><td><p>[REDACTED] Imaging Department, [REDACTED] Cancer Institute, Imaging Nurse-to-Draw</p><p>[REDACTED]</p><p>[REDACTED] Bldg, Fl L1</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter42" class="xRowAlt"><td>[REDACTED] 10:00 AM EDT</td><td ID="encounter42type">Appointment</td><td><p>[REDACTED] Imaging Department, [REDACTED] Cancer Institute, Nuclear Medicine</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter41" class="xRowNormal"><td>[REDACTED]  1:00 PM EDT</td><td ID="encounter41type">Appointment</td><td><p>[REDACTED] Imaging Department, [REDACTED] Cancer Institute, Nuclear Medicine</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter40" class="xRowAlt"><td>[REDACTED]  3:30 PM EDT</td><td ID="encounter40type">Appointment</td><td><p>[REDACTED] Imaging Department, [REDACTED] Cancer Institute, [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED], Fl L1</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter39" class="xRowNormal"><td>[REDACTED] 11:30 AM EDT</td><td ID="encounter39type">Office Visit</td><td><p>BWH [REDACTED] Cardiovascular Clinic</p><p>[REDACTED][REDACTED]</p><p>[REDACTED], MA 02115</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD, PhD</p><p>[REDACTED]</p><p>Department of Cardiology, Ste 4G</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter38" class="xRowAlt"><td>[REDACTED]  4:30 PM EDT</td><td ID="encounter38type">Office Visit</td><td><p>Lank Center for Genitourinary Oncology, [REDACTED] Cancer Institute</p><p>[REDACTED]</p><p>Yawkey Ctr, Fl 11</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p><br/><p>[REDACTED] D, MD, PhD</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter37" class="xRowNormal"><td>[REDACTED]  5:15 PM EDT</td><td ID="encounter37type">Infusion</td><td><p>Infusion Therapy Services Yawkey 11, [REDACTED] Cancer Institute</p><p>[REDACTED]</p><p>Yawkey Ctr Fl 11</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p><br/><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter36" class="xRowAlt"><td>[REDACTED] 10:00 AM EDT</td><td ID="encounter36type">Appointment</td><td><p>Department of Radiation Oncology</p><p>[REDACTED][REDACTED]</p><p>[REDACTED], MA 02115</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD, MPH</p><p>[REDACTED][REDACTED][REDACTED]</p><p>[REDACTED], MA 02115</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter35" class="xRowNormal"><td>[REDACTED] 10:40 AM EDT</td><td ID="encounter35type">Appointment</td><td><p>MEE Glaucoma Main Campus</p><p>[REDACTED][REDACTED]</p><p>1st Fl</p><p>[REDACTED], MA 02114</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD, PhD, MPH</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED][REDACTED]</p></td><td/></tr><tr ID="encounter34" class="xRowAlt"><td>[REDACTED] 10:50 AM EDT</td><td ID="encounter34type">Office Visit</td><td><p>MEE Glaucoma Main Campus</p><p>[REDACTED][REDACTED]</p><p>1st Fl</p><p>[REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD, PhD, MPH</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED][REDACTED]</p></td><td/></tr><tr ID="encounter33" class="xRowNormal"><td>[REDACTED]  2:30 PM EDT</td><td ID="encounter33type">Office Visit</td><td><p>Adult Survivorship Program, [REDACTED] Cancer Institute</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter32" class="xRowAlt"><td>[REDACTED]  1:00 PM EST</td><td ID="encounter32type">Appointment</td><td><p>BWH Pulmonary Function Lab</p><p>[REDACTED][REDACTED]</p><p>PBB Lobby</p><p>[REDACTED], MA 02115</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter28" class="xRowNormal"><td>[REDACTED]</td><td ID="encounter28type">Procedure Pass</td><td><p>BWH Periop</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p></td><td/><td/></tr><tr ID="encounter31" class="xRowAlt"><td>[REDACTED]  9:30 AM EST</td><td ID="encounter31type">Hospital Encounter</td><td><p>BWH Periop</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD, MPH</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td/></tr><tr ID="encounter29" class="xRowNormal"><td>[REDACTED]  9:30 AM EST - [REDACTED] 11:15 AM EST</td><td ID="encounter29type">Surgery</td><td><p>BWH Periop</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p></td><td><p>[REDACTED], MD, MPH</p><p>[REDACTED][REDACTED]</p><p>[REDACTED], MA 02115</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td><span class="content_span">BRONCHOSCOPY FLEXIBLE WITH POSSIBLE CRYO</span></td></tr></tbody></table><table><span style="font-weight:bold; ">Scheduled Procedures</span><colgroup><col width="40%"/><col width="10%"/><col width="25%" span="2"/></colgroup><thead><tr><th>Name</th><th>Priority</th><th>Associated Diagnoses</th><th>Date/Time</th></tr></thead><tbody><tr ID="procedure51"><td><span class="content_span">BRONCHOSCOPY FLEXIBLE</span></td><td/><td><p>Bronchial obstruction</p></td><td>[REDACTED]  9:30 AM EST</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id8" href="#toc">Goals</a></h3><div><span class="content_span">Not on file</span>documented as of this encounter</div><h3><a name="id9" href="#toc">Procedures</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id10" href="#toc">Results</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id11" href="#toc">Visit Diagnoses</a></h3><div><table><colgroup><col width="100%"/></colgroup><thead><tr><th>Diagnosis</th></tr></thead><tbody><tr ID="vdx2" class="xRowNormal"><td><p><span class="content_span">Prostate cancer metastatic to bone</span><span class="content_span"> - Primary</span></p></td></tr><tr ID="vdx30" class="xRowNormal"><td><p><span class="content_span">Bronchial obstruction</span></p></td></tr></tbody></table>documented in this encounter</div><h3><a name="id12" href="#toc">Administered Medications</a></h3><div><span class="content_span">Not on file</span>documented in this encounter</div><h3><a name="id13" href="#toc">Additional Health Concerns</a></h3><div><table><colgroup><col width="50%" span="2"/></colgroup><thead><tr><th>Assessment</th><th>Noted Time</th></tr></thead><tbody><tr class="xRowNormal"><td ID="assessment1">PHQ-9 Depression Total Score: 1</td><td>[REDACTED]  9:40 AM EST</td></tr><tr class="xRowAlt"><td ID="assessment2">PHQ-2 Depression Total Score: 0</td><td>[REDACTED] 10:10 AM EST</td></tr></tbody></table>documented as of this encounter</div><h3><a name="id14" href="#toc">Care Teams</a></h3><div><table ID="ct65"><colgroup><col width="25%" span="3"/><col width="13%"/><col width="12%"/></colgroup><thead><tr><th>Team Member</th><th>Relationship</th><th>Specialty</th><th>Start Date</th><th>End Date</th></tr></thead><tbody><tr class="xRowNormal"><td><p>Nguemeni Tiako, [REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td>PCP - Resident PCP</td><td>Internal Medicine</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr class="xRowAlt"><td><p>[REDACTED], MD, MPH</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td>PCP - General</td><td>Internal Medicine</td><td>[REDACTED]</td><td/></tr><tr class="xRowNormal"><td><p>[REDACTED], PA-C</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED][REDACTED]</p><p>[REDACTED], MA 02115</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td>PCP - NP/PA Co-Manager</td><td>Physician Assistant</td><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr class="xRowAlt"><td><p>Self-Referred, Patient</p></td><td>Referring Physician</td><td/><td>[REDACTED]</td><td/></tr><tr class="xRowNormal"><td><p>[REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td>Primary Oncologist</td><td>Hematology and Oncology</td><td>[REDACTED]</td><td/></tr><tr class="xRowAlt"><td><p>[REDACTED], RN</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td>Primary Infusion Nurse</td><td/><td>[REDACTED]</td><td/></tr><tr class="xRowNormal"><td><p>[REDACTED], RN</p><p>[REDACTED]</p><p>[REDACTED], [REDACTED] 02215</p><p>[REDACTED]</p></td><td>Associate Infusion Nurse</td><td/><td>[REDACTED]</td><td/></tr><tr class="xRowAlt"><td><p>Nguemeni [REDACTED], MD</p><p>NPI: [REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED][REDACTED]</p><p>[REDACTED] (Work)</p><p>[REDACTED] (Fax)</p><p>[REDACTED]</p></td><td>Partners Attributed Provider</td><td/><td>[REDACTED]</td><td>[REDACTED]</td></tr><tr class="xRowNormal"><td><p>[REDACTED], RN</p><p>[REDACTED]</p><p>[REDACTED], MA 02115</p><p>[REDACTED]</p></td><td>Nurse Navigator</td><td/><td>[REDACTED]</td><td/></tr><tr class="xRowAlt"><td><p>[REDACTED], RN</p><p>[REDACTED]</p><p>[REDACTED], MA 02215</p><p>[REDACTED]</p></td><td>Associate Infusion Nurse</td><td/><td>[REDACTED]</td><td/></tr></tbody></table>documented as of this encounter</div><h3><a name="id15" href="#toc">Additional Source Comments</a></h3><div>The information contained in this document represents components of the legal health record. It is not the complete legal health record.Mass General [REDACTED]</div><br/><br/>
</body></html>